Former CFO Peter Kuipers Files Intent to Sell $3.06M in Shares
CLOV has more than doubled off its 52-week low of $1.58.
Summary
Clover Health's former CFO, Peter Kuipers, has filed a Form 144 indicating his intent to sell 886,341 shares valued at approximately $3.06 million.
Key Events · Ownership and Investor Activity · CLOV
-
Former CFO Files Intent to Sell
Peter Kuipers, the company's former Chief Financial Officer, has filed a Form 144.
-
Significant Share Disposition
The filing indicates an intent to sell 886,341 shares of common stock.
-
Substantial Market Value
The proposed sale has an approximate market value of $3.06 million.
-
Shares from Stock Options
The shares were acquired on April 29, 2025, through a stock plan option.
Analysis · CLOV · Finance
This Form 144 indicates that former CFO Peter Kuipers intends to sell a substantial amount of Clover Health shares, valued at approximately $3.06 million. While the company recently achieved its first-ever positive GAAP Net Income, this significant sale by a former key executive could be interpreted as profit-taking or a liquidity event, potentially adding selling pressure to the stock.
How filings like this one have moved
In the 30 days to Sep 17, 2026, 29.6% of the 1708 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.34%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CLOV was trading at $3.48 on NASDAQ in the Finance sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $1.58 to $3.92. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.